Demographic and clinic data for all patients enrolled in each arm of the study
| . | Age, y . | Male/female, n/n . | Race (W/AA) . | Platelets (150-400 × 109/L) . | Creatinine (<1.2 mg/dL) . | LDH (<190 U/L) . | ADAMTS13 activity (>68%), % . |
|---|---|---|---|---|---|---|---|
| Prednisone (n = 14) | 37 (22-63) | 0/14 | 13/1 | 15 (2-94) | 1.04 (0.62-3.34) | 881 (252-1663) | 1.5 (0.5-12.4) |
| CSA (n = 12) | 40 (18-63) | 2/10 | 8/4 | 13 (7-34) | 1.06 (0.66-3.21) | 864 (450-1161) | 2.8 (0.5-7.4) |
| . | Age, y . | Male/female, n/n . | Race (W/AA) . | Platelets (150-400 × 109/L) . | Creatinine (<1.2 mg/dL) . | LDH (<190 U/L) . | ADAMTS13 activity (>68%), % . |
|---|---|---|---|---|---|---|---|
| Prednisone (n = 14) | 37 (22-63) | 0/14 | 13/1 | 15 (2-94) | 1.04 (0.62-3.34) | 881 (252-1663) | 1.5 (0.5-12.4) |
| CSA (n = 12) | 40 (18-63) | 2/10 | 8/4 | 13 (7-34) | 1.06 (0.66-3.21) | 864 (450-1161) | 2.8 (0.5-7.4) |
Values represent the median and range of the data unless otherwise indicated.
AA, African American; W, white.